Go to content
UR Home

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy

URN to cite this document:
DOI to cite this document:
Kattner, Anna-Sophia ; Holler, Ernst ; Herr, Wolfgang ; Reichle, Albrecht ; Wolff, Daniel ; Heudobler, Daniel
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 14 May 2020 09:18


Early relapse of acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an often unsuccessful therapeutic challenge. Since treatment options are few and efficacy is low, new approaches such as de novo allo-HSCT, targeted therapies and biomodulatory drugs have been developed, albeit prognosis is very poor. In this manuscript we present an unusual case ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons